1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PFIZER INC.
26.81 -0.24 (-0.89%)
42.7M
XNYS Volume

XNYS 09 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Drug Approval
China approves Pfizer GLP-1 drug ecnoglutide for weight loss, boosting rivalry with Novo and Lilly See details

US Politician trade disclosures for Pfizer from January 8, 2024 to March 10, 2026

Representative Ro Khanna discloses a trade of $1K-15K in Pfizer, made on February 10, 2026.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.